Indoco Remedies
Indoco Remedies was issued with an FDA Warning Letter on 9 July 2019 following inspection of its facility in Goa, India which cited 3 violations for incomplete batch records, failure to investigate out of specification results and incomplete laboratory records, plus a recommendation to retain a qualified consultant for Data Integrity Remediation activities.
The same site also received a Warning Letter back in 2016 for inadequate complaints handling procedures and failure to follow quality control procedures.
They also had a run in with the EMA in 2018. For a full report, click Buy Report or or sign up for a free trial on Regulatory Incident Monitor (where you can build your own reports about the companies that interest you the most).
Data sources that are checked in generation of this report
By purchasing this report you get access to a Pay as you go Monitor account which will allow you to select companies of your choice for reporting.